Tolga Tanguler
EVP, Chief Commercial Officer · 4 filings · Latest: Mar 4, 2026
ALNYLAM PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | Mar 4, 2026 | Sale | $323.08 | 2,309 | $746.0K | 34,297 | |
ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | Mar 2, 2026 | Sale | $327.65 | 1,598 | $523.6K | 36,606 | |
ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 27, 2026 | Option Exercise | $0.00 | 1,666 | — | 33,435 | |
ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 13, 2026 | Sale | $310.08 | 1,959 | $607.4K | 31,769 | |
ALNY | Tanguler Tolga | — | Aug 29, 2025 | Proposed Sale | $452.22 | 3,474 | $1.6M | — |